Back
Uncategorized

SS-31 Research: Elamipretide Structure, Cardiolipin and Mitochondrial Studies

SS-31 Mitochondrial Research Lab

SS-31, also known as elamipretide, is a mitochondria-targeting tetrapeptide studied for its interaction with mitochondrial membranes, cardiolipin, oxidative stress, electron transport, ATP production, and cellular energy biology.

Its commonly reported sequence is:

D-Arg–2′,6′-dimethylTyr–Lys–Phe-NH₂

Unlike many peptides that act mainly through a classical cell-surface receptor, SS-31 is especially interesting because it accumulates in mitochondria and interacts with the inner mitochondrial membrane.

Research has focused heavily on its relationship with cardiolipin, a phospholipid that helps organize mitochondrial cristae and support electron transport.

This makes SS-31 a useful research compound for studying:

  • Mitochondrial membrane biology
  • Cardiolipin interactions
  • Electron transport
  • ATP synthesis
  • Reactive oxygen species
  • Oxidative stress
  • Cellular aging
  • Ischemia-reperfusion models
  • Mitochondrial structural integrity

For research purposes only. Not for human or veterinary use.

What Is SS-31?

SS-31 is a short synthetic peptide containing four amino-acid residues.

The commonly reported structure is:

D-Arg–dimethylTyr–Lys–Phe-NH₂

It is also known by several names, including:

  • SS-31
  • Elamipretide
  • MTP-131
  • Bendavia in earlier development literature

The peptide belongs to a class of mitochondria-targeting aromatic-cationic peptides.

Its small size and unusual residue composition allow it to interact strongly with mitochondrial membranes.

Research has shown that SS-31 can bind lipid bilayers and alter membrane-surface electrostatics, contributing to its mitochondrial activity.

Why SS-31 Is Different From Many Research Peptides

Many research peptides are studied because they bind a specific extracellular receptor.

Examples include:

  • GLP-1 receptor agonists
  • GHRH analogues
  • Melanocortin peptides
  • Ghrelin-receptor ligands

SS-31 is different.

Its major research focus is the mitochondrial inner membrane.

This gives the peptide a distinct scientific profile.

Instead of beginning with a traditional receptor-signaling pathway, SS-31 research often begins with:

  • Membrane lipids
  • Cardiolipin
  • Mitochondrial cristae
  • Electron transport
  • Oxidative phosphorylation

This is one reason SS-31 research does not substantially overlap with MOTS-c.

MOTS-c is mainly studied as a mitochondrial-derived signaling peptide, while SS-31 is studied primarily as a mitochondria-targeting membrane-active tetrapeptide.

SS-31 Is a Tetrapeptide

SS-31 contains only four amino-acid residues.

That makes it a tetrapeptide.

Its structure includes several unusual features.

D-Arginine

The first residue is D-arginine rather than the naturally common L-form.

D-amino acids can change:

  • Enzyme recognition
  • Peptide stability
  • Conformation
  • Proteolytic resistance

This helps distinguish SS-31 from conventional natural peptides.

Dimethyltyrosine

The second residue is a modified tyrosine known as 2′,6′-dimethyltyrosine.

This aromatic residue is especially important in SS-31 research because aromatic and cationic features help the peptide interact with mitochondrial membrane components.

Lysine

Lysine contributes a positively charged side chain.

Positive charge is important because mitochondrial membranes contain negatively charged phospholipids.

Phenylalaninamide

The C-terminal residue is phenylalanine with an amidated terminus.

Terminal amidation changes peptide chemistry and can influence:

  • Charge
  • Stability
  • Mass
  • Biological behavior

Researchers should therefore verify the complete molecular form rather than only the amino-acid names.

Aromatic-Cationic Peptide Design

SS-31 is often described as an aromatic-cationic peptide.

This refers to the combination of:

  • Positively charged residues
  • Aromatic residues

These features help explain why SS-31 interacts strongly with mitochondrial membranes.

Importantly, SS-31 does not rely solely on mitochondrial membrane potential for accumulation.

Its interaction with lipid membranes, especially cardiolipin-rich membranes, is a major part of its mechanism.

What Is Cardiolipin?

Cardiolipin is a specialized phospholipid found mainly in the inner mitochondrial membrane.

It plays important roles in:

  • Mitochondrial membrane structure
  • Cristae organization
  • Electron transport complexes
  • Cytochrome c interactions
  • Oxidative phosphorylation

Because cardiolipin is highly concentrated in mitochondria, it provides an important molecular target for mitochondrial research.

SS-31 has been shown to bind cardiolipin with high affinity.

Why Cardiolipin Matters for Mitochondrial Function

Mitochondria produce ATP through oxidative phosphorylation.

This process depends on protein complexes embedded in the inner mitochondrial membrane.

Cardiolipin helps maintain the organization and stability of these complexes.

It also contributes to the shape of mitochondrial cristae.

If cardiolipin becomes oxidized or structurally disrupted, mitochondrial efficiency may decline.

Researchers therefore study cardiolipin in relation to:

  • Energy production
  • Oxidative stress
  • Membrane damage
  • Aging
  • Mitochondrial disease

SS-31 is especially relevant because of its direct interaction with this lipid.

SS-31 and Cardiolipin Binding

One of the most important SS-31 studies demonstrated that the peptide binds cardiolipin and changes the interaction between cardiolipin and cytochrome c.

This interaction may help preserve mitochondrial function.

The peptide-cardio­lipin complex has been studied for its ability to:

  • Stabilize mitochondrial membranes
  • Reduce cardiolipin oxidation
  • Preserve electron transfer
  • Limit abnormal cytochrome c peroxidase activity

These effects have become central to SS-31 research.

Cytochrome c and Cardiolipin

Cytochrome c normally participates in electron transport.

It transfers electrons between mitochondrial respiratory complexes.

However, when cytochrome c interacts with oxidized or disrupted cardiolipin under stress conditions, it can develop peroxidase-like activity.

That activity can promote further cardiolipin oxidation.

This creates a damaging cycle.

SS-31 has been studied for its ability to interfere with this process while preserving normal electron-transfer function.

Why Cytochrome c Peroxidase Activity Matters

Under normal conditions, cytochrome c helps transfer electrons.

Under oxidative stress, its interaction with cardiolipin may change.

The cytochrome c–cardiolipin complex can contribute to:

  • Lipid oxidation
  • Mitochondrial membrane damage
  • Loss of membrane organization

SS-31 research has shown that cardiolipin binding may reduce this unwanted peroxidase activity.

This makes SS-31 useful for studying mitochondrial membrane protection.

Mitochondrial Cristae

Cristae are folds of the inner mitochondrial membrane.

They increase membrane surface area.

Many components of the electron transport chain are concentrated there.

Cristae organization depends heavily on:

  • Cardiolipin
  • Protein complexes
  • Membrane curvature

Damage to cristae can reduce mitochondrial efficiency.

SS-31 has been studied in models where mitochondrial cristae structure becomes disrupted.

Research suggests that its interaction with cardiolipin may help support membrane organization.

Electron Transport Chain Research

The mitochondrial electron transport chain includes several major protein complexes.

These are commonly called:

  • Complex I
  • Complex II
  • Complex III
  • Complex IV

Electrons move through these complexes.

The process helps generate the proton gradient used to synthesize ATP.

SS-31 research has investigated whether improved membrane organization can support electron transport efficiency.

This is a different mechanism from directly stimulating a receptor.

ATP Production

ATP is the main cellular energy molecule.

Mitochondria produce much of the ATP used by aerobic cells.

Several studies have reported that SS-31 can improve mitochondrial ATP-related measurements under experimental stress conditions.

Possible explanations include:

  • Improved membrane organization
  • Better electron transfer
  • Reduced oxidative damage
  • Improved ADP handling

However, the effects depend on the model.

SS-31 should not be described as simply “increasing energy” under all conditions.

ADP Sensitivity Research

A 2023 study examined SS-31 in aged mitochondria.

The researchers reported improved ADP sensitivity and linked the effect partly to increased nucleotide transport through the adenine nucleotide translocator.

This is scientifically important because ATP production depends on both:

  • Electron transport
  • Availability of ADP

The findings suggest SS-31 research extends beyond cardiolipin alone.

What Is the Adenine Nucleotide Translocator?

The adenine nucleotide translocator, commonly abbreviated ANT, is a mitochondrial membrane protein.

It exchanges:

  • ADP entering the mitochondrial matrix
  • ATP leaving the mitochondrial matrix

This exchange is essential for normal cellular energy metabolism.

If ADP transport becomes inefficient, ATP synthesis may become limited.

The 2023 SS-31 study provides evidence that ANT-related mechanisms may contribute to improved mitochondrial function in aging models.

Reactive Oxygen Species Research

Reactive oxygen species, or ROS, are chemically reactive molecules produced during cellular metabolism.

Mitochondria are a major source of ROS.

Small amounts of ROS can participate in normal signaling.

Excessive ROS can contribute to:

  • Lipid oxidation
  • Protein damage
  • DNA damage
  • Membrane disruption

SS-31 has been studied extensively in oxidative stress models.

Is SS-31 Simply an Antioxidant?

SS-31 is sometimes called a mitochondrial antioxidant.

That description is incomplete.

Early studies did examine its ability to reduce oxidative damage.

However, later research suggests the peptide may work through multiple mitochondrial mechanisms.

These include:

  • Cardiolipin interaction
  • Membrane electrostatics
  • Electron transport
  • Cytochrome c regulation
  • ATP production

This broader view is more accurate than describing SS-31 only as a free-radical scavenger.

Lipid Peroxidation Research

Lipid peroxidation occurs when reactive molecules damage membrane lipids.

Because mitochondrial membranes contain cardiolipin, oxidative stress can strongly affect them.

An early rat ischemia-reperfusion study reported reduced myocardial lipid peroxidation after SS-31 exposure.

This helped establish SS-31 as an important compound in mitochondrial oxidative-stress research.

Ischemia-Reperfusion Models

Ischemia occurs when tissue receives insufficient blood flow.

Reperfusion occurs when circulation returns.

Although reperfusion is necessary, the sudden return of oxygen can produce significant oxidative stress.

Researchers have used SS-31 in experimental ischemia-reperfusion models involving:

  • Heart tissue
  • Kidney tissue
  • Other organs

These models allow researchers to study mitochondrial injury under acute stress.

Cardiac Research

Early animal studies investigated SS-31 in myocardial ischemia-reperfusion models.

A rat study reported reductions in lipid peroxidation and infarct-related measurements under specific experimental conditions.

These results are preclinical.

They should not be interpreted as clinical treatment guidance.

Kidney Research

SS-31 has also been studied in experimental kidney injury.

A 2019 study examined the peptide in mouse models of acute tubular and glomerular injury.

The researchers reported changes involving:

  • Oxidative stress
  • Inflammatory markers
  • Renin-angiotensin signaling

They also examined aminopeptidase A and angiotensin receptor expression.

This demonstrates that SS-31 research is not limited to one organ system.

Mitochondrial Aging Research

Mitochondrial function often changes with age.

Researchers have examined:

  • Reduced respiratory efficiency
  • Altered ATP production
  • Oxidative stress
  • Changes in membrane structure
  • Reduced ADP sensitivity

SS-31 is increasingly studied in this context.

The 2023 mitochondrial aging study showed that SS-31 may improve ADP sensitivity in aged mitochondria.

This gives SS-31 a distinct role in geroscience research.

SS-31 and MOTS-c Are Different

SS-31 and MOTS-c both appear in mitochondrial research.

They should not be treated as similar compounds.

SS-31

SS-31 is:

  • A synthetic tetrapeptide
  • Mitochondria-targeting
  • Cardiolipin-associated
  • Membrane-active
  • Studied in oxidative phosphorylation

MOTS-c

MOTS-c is:

  • A 16-amino-acid mitochondrial-derived peptide
  • Encoded within mitochondrial DNA
  • Studied in metabolic signaling
  • Associated with AMPK-related pathways

Their research mechanisms are fundamentally different.

SS-31 Does Not Need a Classical Mitochondrial Targeting Sequence

Many mitochondrial proteins enter mitochondria using dedicated targeting sequences.

SS-31 does not use that conventional pathway.

Its small size, charge, and aromatic structure allow a different form of mitochondrial interaction.

This property made SS-31 an important example in the development of mitochondria-targeted peptide research.

Membrane Electrostatics

A 2020 study showed that SS-31 binds lipid bilayers and alters membrane-surface electrostatics.

This finding expanded the mechanistic view of SS-31.

The peptide may influence how membrane proteins interact with the lipid environment.

That could affect:

  • Electron transport
  • Protein organization
  • Membrane stability

This is a broader mechanism than simply scavenging ROS.

Why Membrane Electrostatics Matter

Biological membranes contain charged lipids and proteins.

Electrical interactions can influence:

  • Protein localization
  • Enzyme activity
  • Molecular binding
  • Membrane curvature

Cardiolipin is strongly negatively charged.

SS-31 contains positively charged residues.

This electrostatic relationship is one reason the peptide interacts strongly with cardiolipin-containing membranes.

Peptide Structure-Activity Research

Researchers have also studied SS-31 derivatives.

A 2024 study synthesized multiple SS-31-related peptides and evaluated mitochondrial and inflammatory endpoints in cell models.

This type of work helps researchers determine which structural features are important.

Possible variables include:

  • D-arginine
  • Dimethyltyrosine
  • Aromatic residue placement
  • Charge
  • Terminal amidation

Structure-activity studies can reveal which features are essential for mitochondrial targeting.

Why D-Amino Acids Matter

Most natural proteins use L-amino acids.

D-amino acids can resist certain proteases.

This can improve peptide stability in biological environments.

SS-31 contains D-arginine.

Researchers studying analogues may compare D- and L-residue versions to examine:

  • Stability
  • Membrane interaction
  • Mitochondrial localization
  • Biological response

Terminal Amidation

SS-31 contains a C-terminal amide.

Amidation can change:

  • Net charge
  • Hydrogen bonding
  • Molecular mass
  • Protease susceptibility

When verifying SS-31 identity, researchers should confirm that the expected terminal modification is present.

Analytical Characterization

Research-grade SS-31 should be characterized analytically.

Useful methods may include:

  • HPLC
  • LC-MS
  • Mass spectrometry
  • Peptide sequence confirmation

Because SS-31 contains unusual structural features, analytical verification is especially important.

HPLC Analysis

High-performance liquid chromatography can help evaluate:

  • Main peptide peak
  • Impurity profile
  • Relative purity
  • Batch consistency

A high HPLC percentage does not by itself confirm molecular identity.

Mass Spectrometry

Mass spectrometry can help confirm:

  • Expected molecular mass
  • Modified tyrosine
  • Terminal amidation
  • Truncated species
  • Degradation products

This makes mass spectrometry an important complement to HPLC.

Identity and Purity Are Different

Researchers should separate two questions.

Purity

How much of the detectable sample is the desired primary component?

Identity

Is that component actually SS-31?

A strong Certificate of Analysis should support both.

Storage and Stability

Peptide stability can depend on:

  • Temperature
  • Light
  • Moisture
  • pH
  • Solution composition
  • Storage duration

Researchers should follow product-specific handling documentation.

Once placed into solution, peptide stability may differ from the lyophilized form.

Batch Traceability

Laboratory research should record:

  • Product name
  • Exact chemical identity
  • Batch number
  • Purity
  • Identity result
  • Storage conditions
  • Experimental date

This is especially important when comparing results across laboratories.

Experimental Controls

A strong SS-31 study may include:

  • Untreated control
  • Vehicle control
  • SS-31 treatment
  • Oxidative-stress control
  • Mitochondrial inhibitor
  • Related peptide analogue

The exact controls should match the research question.

Mitochondrial Respiration Assays

Researchers can measure mitochondrial function using oxygen-consumption assays.

Possible endpoints include:

  • Basal respiration
  • ATP-linked respiration
  • Maximal respiration
  • Spare respiratory capacity

These measurements may help determine whether SS-31 changes mitochondrial energy production.

ATP Measurements

ATP can be measured using:

  • Luminescence assays
  • Biochemical methods
  • Mitochondrial functional assays

Researchers should interpret ATP changes together with:

  • Cell viability
  • Oxygen consumption
  • ADP handling
  • Mitochondrial number

An ATP increase alone does not explain the mechanism.

ROS Assays

Reactive oxygen species can be measured using fluorescent probes.

However, these assays can be sensitive to:

  • Probe location
  • Oxidation specificity
  • Cell type
  • Light exposure

Researchers should use multiple methods where possible.

Cardiolipin Analysis

Cardiolipin research may include:

  • Lipidomics
  • Mass spectrometry
  • Oxidation measurements
  • Membrane-binding assays

These methods are especially relevant to SS-31 because cardiolipin is central to its proposed mechanism.

Mitochondrial Morphology

Researchers may use microscopy to study:

  • Cristae structure
  • Mitochondrial fragmentation
  • Fusion
  • Fission
  • Membrane integrity

Electron microscopy can provide detailed information about cristae organization.

This is useful when evaluating membrane-active compounds such as SS-31.

Human Research Background

Elamipretide has been studied clinically in several mitochondrial and cardiovascular conditions.

This clinical history is much broader than that of many research peptides.

However, research-grade SS-31 should not be treated as equivalent to a regulated pharmaceutical product.

Manufacturing, formulation, quality control, and intended use are different.

FDA Approval Status

A major regulatory development occurred in 2025.

On September 19, 2025, the U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) for improving muscle strength in adult and pediatric patients with Barth syndrome who weigh at least 30 kg.

This approval is specific.

It does not mean all SS-31 products are approved medicines.

Research Material vs Approved Elamipretide Drug Product

This distinction is essential.

A research-grade SS-31 material may share the same or similar active peptide identity.

However, it is not automatically the same as:

Forzinity (elamipretide) injection

An FDA-approved drug product is subject to regulated requirements involving:

  • Manufacturing
  • Formulation
  • Sterility
  • Quality control
  • Labeling
  • Clinical use

Research materials should therefore remain clearly separated from approved pharmaceutical products.

Barth Syndrome Research

Barth syndrome is a rare mitochondrial disorder associated with abnormal cardiolipin remodeling.

Because cardiolipin is central to both Barth syndrome biology and SS-31 research, the compound became especially relevant in this field.

The FDA’s 2025 accelerated approval specifically applies to elamipretide for Barth syndrome in patients meeting the labeled weight criteria.

For research-focused content, this should be presented only as regulatory and scientific background.

Why Barth Syndrome Is Mechanistically Relevant

Barth syndrome is associated with abnormalities involving cardiolipin.

Because SS-31 interacts with cardiolipin, the disease provides a scientifically important model for studying:

  • Mitochondrial membrane structure
  • Cardiolipin biology
  • Energy production
  • Muscle function

This connection helped strengthen interest in SS-31’s cardiolipin-related mechanism.

SS-31 Is Not a General-Purpose Mitochondrial Treatment

A common mistake is to interpret mitochondrial activity too broadly.

SS-31 has been studied across many experimental systems.

That does not mean it is proven to treat every condition involving mitochondria.

Researchers should distinguish:

  • Cell models
  • Animal models
  • Human trials
  • Approved indications

The strength of evidence differs greatly between these categories.

Evidence From Cell Models

Cell studies are useful for investigating:

  • Mitochondrial respiration
  • ATP production
  • ROS
  • Membrane potential
  • Inflammatory signaling

They are valuable for mechanism.

However, cell experiments do not reproduce the complexity of an entire organism.

Evidence From Animal Models

Animal studies have examined SS-31 in:

  • Heart injury
  • Kidney injury
  • Aging
  • Neurodegeneration
  • Metabolic stress

These studies provide important biological information.

However, animal findings cannot automatically be translated into human outcomes.

Clinical Research

Clinical development of elamipretide has included multiple mitochondrial-related conditions.

Not every clinical program has produced the same outcome.

Therefore, articles should avoid presenting the entire clinical history as uniformly positive.

The strongest current regulatory statement is the FDA’s specific 2025 accelerated approval for Barth syndrome.

SS-31 and Neurodegenerative Research

Mitochondrial dysfunction and oxidative stress are frequently studied in neurodegenerative models.

SS-31 derivatives have been evaluated in neuronal cell systems involving:

  • ATP production
  • Mitochondrial ROS
  • Inflammatory markers

A 2024 study reported that certain SS-31 derivatives improved ATP-related measurements and reduced inflammatory markers in stressed neuronal cells.

These findings remain preclinical.

SS-31 and Inflammation

Inflammation may change when mitochondrial function changes.

Damaged mitochondria can influence:

  • ROS
  • Innate immune signaling
  • Cellular stress pathways

SS-31 research sometimes reports inflammatory changes alongside mitochondrial improvements.

However, it should not be described simply as an anti-inflammatory peptide.

The primary research mechanism remains strongly mitochondrial.

SS-31 and Aging

Aging research increasingly examines mitochondrial quality.

Important endpoints include:

  • Respiration
  • ATP production
  • Mitochondrial turnover
  • Membrane structure
  • Oxidative stress

SS-31 provides a useful research tool because its mechanism focuses directly on mitochondrial membranes and energy biology.

Why SS-31 Is a Strong Research Topic

SS-31 is scientifically interesting because several distinct research areas converge around one short peptide.

These include:

  • Peptide chemistry
  • Membrane biophysics
  • Lipid biology
  • Mitochondrial physiology
  • Oxidative stress
  • Aging
  • Energy metabolism

This makes it substantially different from most receptor-targeting peptides.

SS-31 Research and Bayoupep USA

For Bayoupep USA, SS-31 can be discussed as a laboratory research compound with emphasis on:

  • Tetrapeptide structure
  • Cardiolipin binding
  • Mitochondrial membrane research
  • Electron transport
  • Oxidative stress studies
  • Analytical characterization

Research materials should be evaluated using batch-specific documentation.

Researchers should confirm:

  • Exact peptide identity
  • Terminal amidation
  • Modified amino-acid composition
  • Purity
  • Mass data
  • Storage instructions

For research purposes only. Not for human or veterinary use.

Key Questions Researchers May Ask About SS-31

Is SS-31 the same as elamipretide?

SS-31 is the research name widely used for the peptide later developed under the generic name elamipretide.

However, a research-grade SS-31 material is not automatically equivalent to an approved pharmaceutical formulation.

How many amino acids are in SS-31?

SS-31 is a tetrapeptide, meaning it contains four residues.

What is the SS-31 sequence?

It is commonly represented as:

D-Arg–2′,6′-dimethylTyr–Lys–Phe-NH₂

What does SS-31 primarily target?

Research strongly emphasizes interaction with cardiolipin-rich mitochondrial membranes.

Is SS-31 a receptor agonist?

Its best-known research mechanism is not based on a single classical cell-surface receptor.

Instead, it is studied mainly for mitochondrial membrane interactions.

Is SS-31 FDA approved?

Elamipretide was granted accelerated FDA approval in September 2025 as Forzinity for a specific Barth syndrome indication.

This does not make general research SS-31 products FDA-approved medicines.

Final Thoughts

SS-31 is one of the most distinctive peptides in mitochondrial research.

Its small tetrapeptide structure:

D-Arg–2′,6′-dimethylTyr–Lys–Phe-NH₂

allows it to interact with mitochondrial membranes in ways that differ from conventional receptor-targeting peptides.

Research has shown that SS-31 binds cardiolipin, alters membrane electrostatics, influences cytochrome c–cardiolipin interactions, and may support mitochondrial function under several experimental stress conditions.

Its major research areas include:

  • Cardiolipin biology
  • Cristae organization
  • Oxidative phosphorylation
  • ATP production
  • Reactive oxygen species
  • Ischemia-reperfusion injury
  • Kidney research
  • Aging-related mitochondrial changes

The peptide has also moved beyond purely experimental status in one specific pharmaceutical context. On September 19, 2025, FDA granted accelerated approval to elamipretide under the trade name Forzinity for certain patients with Barth syndrome.

That regulatory development makes scientific wording particularly important.

Research-grade SS-31 should remain clearly distinguished from an FDA-approved pharmaceutical formulation.

For laboratory work, researchers should prioritize:

  • Correct molecular identity
  • Terminal modification verification
  • HPLC purity testing
  • Mass-spectrometry confirmation
  • Batch traceability
  • Appropriate mitochondrial controls

SS-31 remains a valuable research tool for examining the relationship between peptide chemistry, mitochondrial membranes, cardiolipin, and cellular energy biology.

This information is provided for scientific and educational research purposes only. Research-grade SS-31 is not intended for human or veterinary use.

Keep reading

Related articles

All articles →

Leave a comment

Your email address is never published. Required fields are marked *